Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Exelixis Provides Update on ODAC Panel for Cabozantinib
Exelixis Provides Update on ODAC Panel for Cabozantinib
Exelixis Provides Update on ODAC Panel for Cabozantinib
Submitted by
admin
on August 30, 2012 - 9:46am
Source:
Yahoo
News Tags:
Exelixis
cabozantinib
medullary thyroid cancer
Headline:
Exelixis Provides Update on ODAC Panel for Cabozantinib
Do Not Allow Advertisers to Use My Personal information
